Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Marliese Alexander

Has grant

Deputy Director of Pharmacy (Quality and Research)

Peter MacCallum Cancer Institute

Australia

Research Interests

Explore related searches

Professors in Australia

Recent Grants

Grant: Open

PRECISION– PhaRmacogEnomiC medIcines optimiSatIon for peOple with caNcer

Open Date: 2023-03-01

Close Date: 2027-03-01

Grant: Close

Personalised risk-directed clot prevention for patients with cancer

Open Date: 2021-01-01

Close Date: 2025-01-01

Grant: Close

Towards precision medicine for the prevention of cancer-associated thromboembolism

Open Date: 2018-06-01

Close Date: 2020-06-01

Grant: Close

Thromboprophylaxis for patients with cancer

Open Date: 2017-01-01

Close Date: 2018-01-01

Grant: Close

A prospective randomised controlled pilot study to determine the efficacy and safety of targeted thromboprophylaxis (TP) in adult ambulatory care cancer patients at high risk of thromboembolism (TE)

Open Date: 2017-01-01

Close Date: 2020-01-01

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Collaborators (14)

Senthil Lingaratnam

Director of Pharmacy

Peter MacCallum Cancer Institute

AUSTRALIA

View details

Penelope Schofield

Swinburne University of Technology

AUSTRALIA

View details

Rebecca Bergin

Senior Research Fellow

Deakin University

AUSTRALIA

View details

Lauren Gray

New South Wales Department of Planning and Environment

AUSTRALIA

View details

Abdur Rahim Mohammad Forkan

Senior Research Fellow, AI and Machine Learning

Swinburne University of Technology

AUSTRALIA

View details

Safeera Y. Hussainy

University of Melbourne

AUSTRALIA

View details

An Tran-Duy

Associate Professor

University of Melbourne

AUSTRALIA

View details

Craig Underhill

AUSTRALIA

View details

David Elliott

Group Leader

Murdoch Childrens Research Institute

AUSTRALIA

View details

Kenneth O'Byrne

Queensland University of Technology

AUSTRALIA

View details

Benjamin Solomon

Professor

University of Melbourne

AUSTRALIA

View details

Maarten IJzerman

Full professor

Erasmus University Rotterdam

NETHERLANDS

View details

Chiao Xin Lim

Senior lecturer

RMIT University

AUSTRALIA

View details

Lauren Julia Brown

University of Sydney

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Marliese Alexander

Research Interests

Explore related searches

Recent Grants

Articles (20)

Diagnostic Delays in Thoracic Cancer Care: A Data-Linkage, Cohort Study between Primary Care, Hospital, and Registry Data

Real-world treatment sequencing and survival in ROS1-Rearranged NSCLC across evolving treatment eras: Findings from the AURORA multi-centre registry (AURORA-ROS1)

Pre-emptive DPYD genotyping and fluoropyrimidine dose optimisation: Dose tolerance and survival in cancer patients

Long-term survival outcomes after biomarker-guided thromboprophylaxis in cancer: extended follow-up of the TARGET-TP randomized trial

Impact of PD-L1 on first-line osimertinib outcomes in EGFR-mutant NSCLC: real-world data from the AURORA25 study and meta-analysis

Digital Solution to Support Medication Adherence and Self-Management in Patients with Cancer (SAMSON): Pilot Randomized Controlled Trial

Informing Implementation Strategies for Pharmacogenomics in Cancer: Development of Survey Tools for Healthcare Professionals and Consumers

Second-line treatment strategies and clinical outcomes after progression on chemoimmunotherapy in extensive-stage small-cell lung cancer

Pharmacogenomics in pediatric oncology: Australian adolescent or young adult and caregiver perspectives

Real-World Treatment and Outcomes in ALK-Rearranged NSCLC

First-line chemoimmunotherapy and immunotherapy in patients with non-small cell lung cancer and brain metastases: a registry study

Completion of Pembrolizumab in Advanced Non-Small Cell Lung Cancer—Real World Outcomes After Two Years of Therapy (COPILOT)

Pharmacogenetics testing (DPYD and UGT1A1) for fluoropyrimidine and irinotecan in routine clinical care: Perspectives of medical oncologists and oncology pharmacists

Infective complications in cancer patients treated with subcutaneous versus intravenous trastuzumab and rituximab: An individual patient data meta-analysis

Utility of 30-Day Mortality Following Systemic Anti-Cancer Treatment as a Quality Indicator in Advanced Lung Cancer

Lurbinectedin in small cell lung cancer: real‐world experience of a multicentre national early access programme

The impact of pre-treatment smoking status on survival after chemoradiotherapy for locally advanced non-small-cell lung cancer.

Healthcare professionals' and consumers' knowledge, attitudes, perspectives, and education needs in oncology pharmacogenomics: A systematic review

Telehealth in oncology: a cost analysis to evaluate the financial impact of implementing regional trial hubs within a phase 3 cancer clinical trial

A systematic review of knowledge, attitude and practice of pharmacogenomics in pediatric oncology patients

Collaborators (14)

Senthil Lingaratnam

Penelope Schofield

Rebecca Bergin

Lauren Gray

Abdur Rahim Mohammad Forkan

Safeera Y. Hussainy

An Tran-Duy

Craig Underhill

David Elliott

Kenneth O'Byrne

Benjamin Solomon

Maarten IJzerman

Chiao Xin Lim

Lauren Julia Brown

Make your next move.